Thinking globally Company Notes Bionomics (ASX:BNO) Acquired French company Neurofit in 2005, giving it preclinical CNS development capabilities Biota (ASX:BTA) Acquired U.S. antiviral company NuMax in 2001 Bone Medical (ASX:BNE) Osteoporosis and arthritis company with...

CYN said it is seeking to out-license its stem cell expansion and T cell production technologies to focus on its tissue and cord blood banking business. The company said it will continue to expand these...

Cord blood banking and cell therapy company CYN sold its Cell Sciences Pte Ltd. subsidiary, which distributes medical and research products, for a 20% stake in DNAPro. CYN said the equity stake is valued at...

CYN purchased a 20% stake in PharmaCell for an undisclosed amount of cash. In exchange, CYN said it will have access to PharmaCell's cGMP manufacturing facility, where it will manufacture cell therapy products. CYN, which...

CyGenics Ltd. (ASX:CYN), Melbourne, Australia Business: Gene/Cell therapy Appointed: Alberto Bautista, an industry consultant WIR Staff...

CyGenics Ltd. (ASX:CYN), Sydney, Australia Business: Gene/Cell therapy Hired: Mark Kirkland as CSO, formerly CEO of BioCell Pty Ltd. WIR Staff...

In mice, thymus-derived stem cells cultured on skin cells did not produce graft-versus-host disease (GVHD). CYN's ex vivo T cell production technology generates T cells from autologous skin cells and bone marrow stem cells for...